Critical Analysis: Cogentix Medical (CGNT) and Thermo Fisher Scientific (TMO)
Cogentix Medical (NASDAQ: CGNT) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.
Institutional & Insider Ownership
12.7% of Cogentix Medical shares are held by institutional investors. Comparatively, 83.5% of Thermo Fisher Scientific shares are held by institutional investors. 35.5% of Cogentix Medical shares are held by insiders. Comparatively, 0.5% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares Cogentix Medical and Thermo Fisher Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Thermo Fisher Scientific||11.80%||15.97%||7.48%|
Volatility and Risk
Cogentix Medical has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.
Thermo Fisher Scientific pays an annual dividend of $0.60 per share and has a dividend yield of 0.3%. Cogentix Medical does not pay a dividend. Thermo Fisher Scientific pays out 10.5% of its earnings in the form of a dividend.
This is a breakdown of current recommendations and price targets for Cogentix Medical and Thermo Fisher Scientific, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Thermo Fisher Scientific||0||1||14||1||3.00|
Thermo Fisher Scientific has a consensus price target of $193.36, suggesting a potential upside of 0.99%. Given Thermo Fisher Scientific’s higher possible upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Cogentix Medical.
Earnings & Valuation
This table compares Cogentix Medical and Thermo Fisher Scientific’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Cogentix Medical||$53.65 million||3.17||$3.20 million||($0.41)||-6.80|
|Thermo Fisher Scientific||$19.20 billion||3.89||$4.81 billion||$5.74||33.36|
Thermo Fisher Scientific has higher revenue and earnings than Cogentix Medical. Cogentix Medical is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.
Thermo Fisher Scientific beats Cogentix Medical on 13 of the 15 factors compared between the two stocks.
About Cogentix Medical
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.
Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.